UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOYU
1401
DouYu International Holdings
DOYU
$142M
| $3.85M | ﹤0.01% |
36,950
+184
| +0.5% | +$24.9K |
|
1402
Sensient Technologies
SXT
$5.53B
| $3.84M | ﹤0.01% |
49,246
-1,095
| -2% | -$84.1K |
|
1403
Quaker Houghton
KWR
$2.92B
| $3.82M | ﹤0.01% |
15,679
-51
| -0.3% | -$13.6K |
|
1404
Qualys
QLYS
$6.35B
| $3.82M | ﹤0.01% |
36,437
-71
| -0.2% | -$7.95K |
|
|
MDC
1405
DELISTED
M.D.C. Holdings, Inc.
MDC
| $3.82M | ﹤0.01% |
64,249
-446
| -0.7% | -$23.4K |
|
1406
ABM Industries
ABM
$2.84B
| $3.81M | ﹤0.01% |
74,674
+2,561
| +4% | +$112K |
|
1407
Fulton Financial
FULT
$4.64B
| $3.8M | ﹤0.01% |
223,167
+14,705
| +7% | +$228K |
|
|
RETA
1408
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $3.79M | ﹤0.01% |
38,028
-372
| -1% | -$43.4K |
|
1409
Wolverine World Wide
WWW
$1.55B
| $3.79M | ﹤0.01% |
98,905
+457
| +0.5% | +$15.8K |
|
|
MDLA
1410
DELISTED
Medallia, Inc.
MDLA
| $3.79M | ﹤0.01% |
135,852
+10,000
| +8% | +$371K |
|
1411
Kennametal
KMT
$2.52B
| $3.77M | ﹤0.01% |
94,359
-6,964
| -7% | -$271K |
|
|
CVET
1412
DELISTED
Covetrus, Inc. Common Stock
CVET
| $3.77M | ﹤0.01% |
125,756
+19,902
| +19% | +$679K |
|
1413
Veracyte
VCYT
$3.8B
| $3.77M | ﹤0.01% |
70,103
+12,253
| +21% | +$706K |
|
1414
Korn Ferry
KFY
$4.28B
| $3.77M | ﹤0.01% |
60,404
-1,490
| -2% | -$82.8K |
|
|
NUVA
1415
DELISTED
NuVasive, Inc.
NUVA
| $3.76M | ﹤0.01% |
57,309
-2,010
| -3% | -$121K |
|
1416
Franklin Electric
FELE
$4.84B
| $3.76M | ﹤0.01% |
47,590
+441
| +0.9% | +$33.1K |
|
|
GBT
1417
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.74M | ﹤0.01% |
91,882
+2,370
| +3% | +$109K |
|
1418
Atkore
ATKR
$3.16B
| $3.74M | ﹤0.01% |
51,981
-1,341
| -3% | -$81.1K |
|
1419
H.B. Fuller
FUL
$3.28B
| $3.74M | ﹤0.01% |
59,402
-2,720
| -4% | -$155K |
|
|
ISBC
1420
DELISTED
Investors Bancorp, Inc.
ISBC
| $3.72M | ﹤0.01% |
253,254
-19,528
| -7% | -$252K |
|
1421
Murphy Oil
MUR
$4.78B
| $3.72M | ﹤0.01% |
226,646
-8,510
| -4% | -$133K |
|
|
SNBR
1422
DELISTED
Sleep Number
SNBR
| $3.69M | ﹤0.01% |
25,728
+1,300
| +5% | +$156K |
|
1423
Glaukos
GKOS
$10.6B
| $3.69M | ﹤0.01% |
43,955
-16
| -0% | -$1.41K |
|
1424
CNO Financial Group
CNO
$5.1B
| $3.69M | ﹤0.01% |
151,771
-32,341
| -18% | -$770K |
|
1425
Houlihan Lokey
HLI
$9.02B
| $3.68M | ﹤0.01% |
55,399
-69
| -0.1% | -$4.66K |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.